Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermLiab,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,changeToNetincome,capitalExpenditures,changeToInventory,changeToAccountReceivables,WC,language,region,quoteType,triggerable,quoteSourceName,exchange,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketPreviousClose,bid,ask,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,marketState,market,shortName,exchangeDataDelayedBy,esgPopulated,tradeable,priceHint,regularMarketChangePercent,regularMarketDayRange,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,WPS.DE,1894800000.0,73823696,13800000,,219600000,,187300000,91400000,315100000,211400000,211400000,-1500000,-1900000,,,,32300000,723600000,512200000,408500000,8200000,,187300000,187300000,27800000.0,248000000.0,900900000.0,2032600000.0,165800000.0,2933500000.0,18800000.0,75100000.0,2160200000.0,120500000.0,110000000.0,-394400000.0,71100000.0,576200000.0,472600000.0,28800000.0,2300000.0,-133200000.0,1035900000.0,1477000000.0,211700000.0,480500000.0,251800000.0,345200000.0,205100000.0,,0.0,-55900000.0,-500000.0,300000.0,-73600000.0,14100000.0,92500000.0,-700000.0,3700000.0,144400000.0,28800000.0,1000000.0,-12600000.0,1900000.0,-56900000.0,,,1004400000.0,en-US,US,EQUITY,False,Delayed Quote,GER,EUR,376.8,1630510537,0.0,376.8,376.8,376.8,7,376.8,377.6,388.8,finmb_313784,XETRA,"West Pharmaceutical Services, Inc.",USD,9,2,160.79999,0.7444444,216.0 - 388.4,-11.600006,-0.029866133,216.0,388.4,1619676009,1634733000,1635165000,0.66,80.59892,0.0017515925,REGULAR,de_market,"WEST PHARM.SVCS  DL-,25",0,False,False,2,0.0,376.8 - 376.8,4.675,24.783,351.64572,25.154266,0.07153298,285.44647,91.353516,0.3200373,27816767488,15.203969,15,Europe/Berlin,CEST,7200000,1.0,,,388.4,216.0,351.65,285.45,9,2,73.82M,,73.48M,0.64%,95.10%,,,,,,0.57,0.16%,0.66,0.18%,,2.48%,,"Jul 20, 2021",,,"Dec 31, 2020","Jun 30, 2021",20.58%,24.47%,14.49%,28.54%,2.52B,34.09,37.30%,767.8M,732.1M,519.2M,4.68,105.40%,576.2M,7.79,319.4M,15.71,3.12,24.78,500.4M,176.91M,Value,19341-0645,Healthcare,9200,8,6,"West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.",Exton,610 594 2900,PA,7,1609372800,1625097600,5,United States,http://www.westpharma.com,86400,7,530 Herman O. West Drive,Medical Instruments & Supplies
t-1,WPS.DE,1690800000.0,73823696,12200000,,179900000,,151200000,79200000,271900000,178300000,178300000,2200000,-1900000,,,,28700000,670700000,492400000,398800000,1600000,,151200000,151200000,28700000.0,246700000.0,910700000.0,1829000000.0,194500000.0,2739700000.0,18800000.0,67400000.0,1985400000.0,118200000.0,109500000.0,-421900000.0,67300000.0,483700000.0,482800000.0,27900000.0,2300000.0,-140200000.0,995300000.0,1327000000.0,211900000.0,465700000.0,252300000.0,310200000.0,204300000.0,,0.0,-54500000.0,-600000.0,-156400000.0,-94900000.0,7600000.0,-131800000.0,-150800000.0,-9600000.0,88700000.0,29100000.0,200000.0,-12600000.0,3300000.0,-54700000.0,,,844200000.0,en-US,US,EQUITY,False,Delayed Quote,GER,EUR,376.8,1630510537,0.0,376.8,376.8,376.8,7,376.8,377.6,388.8,finmb_313784,XETRA,"West Pharmaceutical Services, Inc.",USD,9,2,160.79999,0.7444444,216.0 - 388.4,-11.600006,-0.029866133,216.0,388.4,1619676009,1634733000,1635165000,0.66,80.59892,0.0017515925,REGULAR,de_market,"WEST PHARM.SVCS  DL-,25",0,False,False,2,0.0,376.8 - 376.8,4.675,24.783,351.64572,25.154266,0.07153298,285.44647,91.353516,0.3200373,27816767488,15.203969,15,Europe/Berlin,CEST,7200000,1.0,,,388.4,216.0,351.65,285.45,9,2,73.82M,,73.48M,0.64%,95.10%,,,,,,0.57,0.16%,0.66,0.18%,,2.48%,,"Jul 20, 2021",,,"Dec 31, 2020","Jun 30, 2021",20.58%,24.47%,14.49%,28.54%,2.52B,34.09,37.30%,767.8M,732.1M,519.2M,4.68,105.40%,576.2M,7.79,319.4M,15.71,3.12,24.78,500.4M,176.91M,Value,19341-0645,Healthcare,9200,8,6,"West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.",Exton,610 594 2900,PA,7,1609372800,1625097600,5,United States,http://www.westpharma.com,86400,7,530 Herman O. West Drive,Medical Instruments & Supplies
t-2,WPS.DE,1712900000.0,73823696,12900000,,118800000,,98400000,75300000,211100000,121000000,121000000,1900000,-2100000,,,,20400000,580200000,459200000,369100000,-2200000,,98400000,98400000,30500000.0,267300000.0,939300000.0,1854500000.0,128800000.0,2793800000.0,18800000.0,51600000.0,1846700000.0,117000000.0,111100000.0,-278300000.0,52300000.0,615500000.0,503400000.0,16000000.0,2300000.0,-110600000.0,1011500000.0,1373700000.0,214700000.0,385300000.0,258500000.0,321300000.0,213100000.0,400000.0,36600000.0,-57600000.0,-600000.0,-8700000.0,98800000.0,4500000.0,96100000.0,-150800000.0,13700000.0,148700000.0,28500000.0,-3700000.0,-12600000.0,6700000.0,-57700000.0,-73700000.0,-46600000.0,870300000.0,en-US,US,EQUITY,False,Delayed Quote,GER,EUR,376.8,1630510537,0.0,376.8,376.8,376.8,7,376.8,377.6,388.8,finmb_313784,XETRA,"West Pharmaceutical Services, Inc.",USD,9,2,160.79999,0.7444444,216.0 - 388.4,-11.600006,-0.029866133,216.0,388.4,1619676009,1634733000,1635165000,0.66,80.59892,0.0017515925,REGULAR,de_market,"WEST PHARM.SVCS  DL-,25",0,False,False,2,0.0,376.8 - 376.8,4.675,24.783,351.64572,25.154266,0.07153298,285.44647,91.353516,0.3200373,27816767488,15.203969,15,Europe/Berlin,CEST,7200000,1.0,,,388.4,216.0,351.65,285.45,9,2,73.82M,,73.48M,0.64%,95.10%,,,,,,0.57,0.16%,0.66,0.18%,,2.48%,,"Jul 20, 2021",,,"Dec 31, 2020","Jun 30, 2021",20.58%,24.47%,14.49%,28.54%,2.52B,34.09,37.30%,767.8M,732.1M,519.2M,4.68,105.40%,576.2M,7.79,319.4M,15.71,3.12,24.78,500.4M,176.91M,Value,19341-0645,Healthcare,9200,8,6,"West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.",Exton,610 594 2900,PA,7,1609372800,1625097600,5,United States,http://www.westpharma.com,86400,7,530 Herman O. West Drive,Medical Instruments & Supplies
t-3,WPS.DE,1579000000.0,73823696,12500000,,103400000,,82300000,75900000,194600000,106700000,106700000,-500000,-2100000,,,,21100000,548000000,441300000,353400000,-3300000,,82300000,82300000,30600000.0,268200000.0,863900000.0,1718900000.0,156900000.0,2582800000.0,18800000.0,51000000.0,1773400000.0,98900000.0,109300000.0,-341500000.0,44100000.0,519400000.0,447700000.0,22300000.0,2300000.0,-159500000.0,950900000.0,1238300000.0,209600000.0,373000000.0,257400000.0,294900000.0,180300000.0,,0.0,-49100000.0,-600000.0,-7200000.0,1900000.0,5300000.0,73500000.0,-150800000.0,11200000.0,118600000.0,28400000.0,-1600000.0,-11900000.0,6000000.0,-47500000.0,-73700000.0,-46600000.0,790600000.0,en-US,US,EQUITY,False,Delayed Quote,GER,EUR,376.8,1630510537,0.0,376.8,376.8,376.8,7,376.8,377.6,388.8,finmb_313784,XETRA,"West Pharmaceutical Services, Inc.",USD,9,2,160.79999,0.7444444,216.0 - 388.4,-11.600006,-0.029866133,216.0,388.4,1619676009,1634733000,1635165000,0.66,80.59892,0.0017515925,REGULAR,de_market,"WEST PHARM.SVCS  DL-,25",0,False,False,2,0.0,376.8 - 376.8,4.675,24.783,351.64572,25.154266,0.07153298,285.44647,91.353516,0.3200373,27816767488,15.203969,15,Europe/Berlin,CEST,7200000,1.0,,,388.4,216.0,351.65,285.45,9,2,73.82M,,73.48M,0.64%,95.10%,,,,,,0.57,0.16%,0.66,0.18%,,2.48%,,"Jul 20, 2021",,,"Dec 31, 2020","Jun 30, 2021",20.58%,24.47%,14.49%,28.54%,2.52B,34.09,37.30%,767.8M,732.1M,519.2M,4.68,105.40%,576.2M,7.79,319.4M,15.71,3.12,24.78,500.4M,176.91M,Value,19341-0645,Healthcare,9200,8,6,"West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.",Exton,610 594 2900,PA,7,1609372800,1625097600,5,United States,http://www.westpharma.com,86400,7,530 Herman O. West Drive,Medical Instruments & Supplies
